SanBio Company LimitedTSE 4592

サンバイオ株式会社 · Pharmaceutical · FY ends Jan

Share price at FY-end
—
FY ending Jan 2026
Market cap at FY-end
—
Dividend per share
—
Avg. director pay
¥24.5M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 川西 徹 12,221,186 15.66% — —
2 森 敬太 5,997,284 7.68% — —
3 株式会社SBI証券 1,294,829 1.65% — —
4 野村證券株式会社
Asset-management company of 野村 浩子
1,147,291 1.47% — —
5 大高 功 500,000 0.64% — —
6 マネックス証券株式会社 444,013 0.56% — —
7 松井証券株式会社 264,900 0.33% — —
8 SMBC日興証券株式会社 244,099 0.31% — —
9 安井 勝孝 229,500 0.29% — —
10 GMOクリック証券株式会社 223,700 0.28% — —

Officers' holdings and pay

NameTitleSharesValuePay
川西 徹 Chairman & Representative Director 12,221,186 — —
森 敬太 President, Representative Director & Executive Officer 5,997,284 — —
Noboru Furuya Director 157,143 — —
棚橋 正顕 Full-time Audit & Supervisory Board Member — — —
植田 俊道 Audit & Supervisory Board Member 6,329 — —
山角 健 Audit & Supervisory Board Member 40,000 — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Jan 2026 — ¥-52.55 — — 78,033,331
FY ending Jan 2025 — ¥-41.86 — — 70,927,202
Source: annual securities reports on EDINET. Values are estimates. Methodology